Trichomonas Vaginalis

Pol, Barbara Van Der

doi:10.1002/9781119380924.ch17

Cited by 2 publications

(2 citation statements)

References 69 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Este parásito puede causar otras patologías como vaginitis, cervicitis y uretritis y en los hombres síndrome genitourinario. Este parásito puede ser un cofactor del virus de inmunodeficiencia humana (VIH), por lo cual el control del parásito es clave para disminuir riesgos de ETS mayores [25]. El parásito puede presentar endosimbiosis con Mycoplasma hominis, ocasionando con esta interacción un aumento en la tasa de crecimiento y la producción de ATP del parásito; adicionalmente M. hominis contribuye en los procesos inflamatorios [26].…”

Section: Trichomonas Vaginalisunclassified

Protist Diversification

Simpson¹,

Eglit²

2016

Encyclopedia of Evolutionary Biology

View full text Add to dashboard Cite

Section: Trichomonas Vaginalisunclassified

Protist Diversification

Simpson¹,

Eglit²

2016

Encyclopedia of Evolutionary Biology

View full text Add to dashboard Cite

“…This causes the available screening and diagnostic equipment to be inadequate. 5 Trichomoniasis can occur in men and women with equal frequency, but symptoms in men are milder and disappear within a few weeks. Meanwhile, in women, infection can occur for several years with some symptoms such as pruritus and smelly vaginal discharge.…”

Section: Introductionmentioning

confidence: 99%

Prevalence of Trichomoniasis in Cervical Cancer Patients

Ayuning

Risma

Utami

2022

MHSJ

View full text Add to dashboard Cite

Backgroud: Trichomoniasis is the most frequent non-viral sexually transmitted disease in the world, and it can lead to persistent HPV infection. Trichomonas vaginalis infection causes damage to the vaginal mucosa, activation of oncogenes and inactivation of tumor suppressor proteins, and production of non-specific oxidants that lead to cervical cancer. This study aims to determine the prevalence of trichomoniasis in cervical cancer patients. Methods: This study uses systematic literature review method and uses 10 international journals obtained through machine learning and indexed in Scimago. Journals are screened through PRISMA and have gone through a critical appraisal process.This study took place from April to September 2021. Results: The prevalence of trichomoniasis in cervical cancer patients ranged from 0.022% to 87.7%, according to the findings of this study. The prevalence results vary due to differences in demographics and diagnostic methods used. Statistical analysis of the association between trichomoniasis and cervical cancer varied between significant and insignificant. Differences in the association are influenced by the research design used, diagnostic methods, and sample of the research. Conclusions: The conclusion of this study is that the prevalence of trichomoniasis in cervical cancer patients was discovered to be the highest in the study by Ghosh et al. in Kolkata, India (72.6% women with CIN 1, 71.0% women with CIN 2 or CIN 3, and 87.7% women with invasive cancer) and the lowest in the study by Su et al. in Taiwan (0.022%). The association between trichomoniasis and cervical cancer was found to be varied.

show abstract

Trichomonas Vaginalis

Cited by 2 publications

References 69 publications

Protist Diversification

Protist Diversification

Prevalence of Trichomoniasis in Cervical Cancer Patients

Contact Info

Product

Resources

About